Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

EXoPERT EMERALD Clinical Study

EXoPERT · with MCRA · NCT07186296

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1400
US sites recruiting
9
Study start
May 9, 2025
Record last updated
July 1, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to establish a multi-center clinical repository of blood samples to support the development and evaluation of an artificial intelligence-based in vitro diagnostic software. The software analyzes surface-enhanced Raman spectroscopy (SERS) profiles of extracellular vesicles (EVs) extracted from human plasma for the early detection of multiple cancers, including lung, ovarian, breast, pancreatic, and colorectal cancers.

Being studied: EXoPred

Conditions: Breast Cancer; Colon Cancer; Pancreatic Cancer; Ovarian Cancer; Lung Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Subject aged 45 years or older with a biopsy-proven or clinically suspected primary lung, breast, colorectal, pancreatic, or ovarian cancer, based on objective findings such as radiological, serological, endoscopic, or cytological findings, whose blood was collected prior to any systemic or definitive therapy for the cancer.
  • Subjects who are willing and able to provide written informed consent.
  • Subjects who are willing and able to comply with the study requirements.

Exclusion Criteria

  • Any history of cancer diagnosed and treated within 5 years prior to the date of consent.
  • Subjects with a history of previous cancer treatment via surgical resection, hormonal cancer treatment, chemotherapy, radiotherapy within the past 6 months for recent cancer diagnosis.
  • Subjects who have any history of an allogeneic bone marrow, stem cell transplant, or solid organ transplant.
  • Subjects who are pregnant or breastfeeding women.
  • Subjects who have consented and have undergone treatment in any other cancer related clinical trials withinthe past 6 months.
  • Subjects who are currently in active treatment for drug abuse.
  • Subjects who have received any treatment related to lung, breast, colorectal, pancreatic, or ovarian nodules, such as hormones prior to entering the study.
  • Unsuitable sample for testing due to contamination, hemolysis, etc.

Recruiting US locations

  • Tibor Rubin VA Medical Center

    Long Beach, CA 90822

    Site contact: Neha Shah, PhD, CCRP · 562-826-8000 · Neha.Shah3@va.gov

  • City of Hope Duarte Cancer Center

    Los Angeles, CA 91010

    Site contact: Angelica Hamilton · 626-218-0109 · ahamilton@coh.org

  • University of Hawaii Cancer Center

    Honolulu, HI 96813

    Site contact: Shawn Iwata, RN · 808-564-3992 · siwata@cc.hawaii.edu

  • Lexington VA Healthcare System

    Lexington, KY 40502

    Site contact: Rebekah Evans, RN, BSN, CCRP · 859-233-4511 · Rebekah.evans1@va.gov

  • KCTL

    Louisville, KY 40202

    Site contact: Yenny Lamazares · 502-569-0337 · ylamazares@kentuckyctl.com

  • John Hopkins University

    Baltimore, MD 21218

    Site contact: Jonathan Dudley, M.D. · 410-955-5000 · jdudley5@jh.edu

  • Albany Stratton VA Medical Center

    Albany, NY 12208

    Site contact: Jennifer Thomson, MA · (518) 915-4286 · jennifer.thomson@va.gov

  • Bronx Veterans Medical Research Foundation

    The Bronx, NY 10468

    Site contact: Serena Yeung · 718-584-9000 · serena.yeung@va.gov

  • VA Hudson Valley Healthcare System

    Wappingers Falls, NY 12590

    Site contact: Serena Yeung · 718-584-9000 · serena.yeung@va.gov

Study contacts (from the official record)

  • Young Park · (+82) 02 923 8833 · paark76@korea.ac.kr
  • Yeonho Choi · (+82) 02 923 8833 · yeonhochoi@exopert.com
All healthy volunteers studies in California →
EXoPERT EMERALD Clinical Study (NCT07186296) | Bored Studies